Multiple Myeloma

Multiple myeloma is a cancer of plasma cells which are a type of white blood cells. Some of the most common symptoms and signs are elevated calcium, renal failure, anemia and bone lesions. Opportunistic infections are also typical in those with multiple myeloma. Treatment options include targeted therapy, chemotherapy, biological therapy, radiotherapy or bone marrow transplantation. 

Hanna Olivas wants to be able to get a prescription for a life-ending drug when she's ready, but her home state won't allow it.At 45, Hanna Olivas doesn’t want to die, but she wants the right to end her life on her terms when the time comes.With perhaps one year left to live, the mother and …

Nektar Therapeutics (NKTR +0.3%) initiates a Phase 1 clinical trial evaluating NKTR-255 in patients with relapsed/refractory non-Hodgkin lymphoma …

Updated Tool for 2019 Helps Patients Create Their Most Valuable Plan for Managing Multiple MyelomaGilmore Joins Baseball Hall of Famer Dave Winfield …

Disease factors such as tumor burden and molecular risk affect myeloma patient outcomes as well as patient factors that impact the capacity to …

I-Mab Biopharma has received IND clearances to expand the ongoing phase II and III clinical trials of TJ202/MOR202, MorphoSys's (NASDAQ:MOR) human …

Hanna Olivas knows that she is dying from multiple myeloma, a rare blood cancer, and she knows exactly how she wants her loved ones to think about …

Bob Orr, a longtime member of the Cal sports medicine staff who served as head athletic trainer for 24 years and was inducted into the school's …

In 1850, the Scottish physician William MacIntyre described one of the earliest documented cases of multiple myeloma (MM) in the report “Case of …

Late diagnosis remains the major cause of concern in treating cases of myeloma, a type of blood cancer caused by malignancy of plasma cells …

Revolutionary new Direct-to-Patient Registry brings together clinical, genomic, immune and longitudinal data to accelerate precision medicineThe …

At their most basic level, many of the deadliest diseases are caused by nests of misguided proteins. Most medicines work by attaching themselves to …

Hanna Olivas knows that she is dying from multiple myeloma, a rare blood cancer, and she knows exactly how she wants her loved ones to think about her when she’s gone.“I want my family to remember me smiling, happy, peaceful and loving life,” the mother-of-four, who lives in Las Vegas with husband …...

NEW DELHI : Even as cancer races to become the world’s biggest killer, many of these seemingly effective drugs do not succeed in advancing to …

Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046–60.Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. …

Plasma cells, the malignant cells in multiple myeloma (MM), express high levels of CD38. Daratumumab, the first CD38-targeting therapeutic antibody, …

James Anthony Schleicher Sr. of Bel Air died at his home Oct. 6. He was 57.Schleicher loved biking, camping, family and the Ravens, according to his …

Experts from Europe, USA, China, Japan and Australia shared their recent work in presentations (https://vimeo.com/showcase/5456812).Organizers: Oluf …

Swerdlow SH, Cook JR, Sohani AR, Pileri SA, Harris NL, Jaffe ES, et al. Lymphoplasmacytic lymphoma. In: Swerdlow SH et al., editors. WHO …

Humira’s reign as the world's best-selling drug could soon come to an end.While the drug, manufactured by AbbVie and prescribed to treat Rheumatoid Arthritis, raked in nearly $20 billion in 2018, another drug is on pace to bring in $22.5 billion in a few years.According to an analysis from …

Karyopharm of Israel and Massachusetts gets FDA approval for XPOVIO, the first drug aimed to help natural tumor-suppressing proteins do their job.The …

Submit Post

By posting to this website and replying to posts you agree to these rules.